These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3450611)

  • 1. Graves' ophthalmopathy--role of radiation therapy.
    Datta NR; De S; Rath GK; Chander S
    Indian J Ophthalmol; 1987; 35(1):27-31. PubMed ID: 3450611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy for Graves' ophthalmopathy].
    Zheng J; Zhang X; Gong R; Wang J; Tan T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current role of radiotherapy in immunogenic exophthalmos].
    Malinverni G; Giordana C; Rosmino C; Mancini A; Sala S
    Radiol Med; 1994 Nov; 88(5):665-9. PubMed ID: 7824786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of radiation therapy for Graves' ophthalmopathy.
    Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
    Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Orbit decompression surgery in patients with exophthalmos caused by Graves-Basedow disease].
    Pliego-Maldonado A; Miranda-Ruiz R; Vargas-Aguayo A; Marín-Méndez JA; Peña-García JF; Guerra-López J
    Gac Med Mex; 2000; 136(1):11-5. PubMed ID: 10721594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids in the medical management of Graves' ophthalmopathy.
    Hart RH; Perros P
    Minerva Endocrinol; 2003 Sep; 28(3):223-31. PubMed ID: 14605604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular muscle surgery in Graves' disease.
    Dyer JA
    Trans Am Ophthalmol Soc; 1978; 76():125-39. PubMed ID: 582486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interdisciplinary diagnosis and treatment of endocrine orbitopathy (Graves' disease) (author's transl)].
    Wulle KG; Brunk G; Utech C; Pfannenstiel P
    Klin Monbl Augenheilkd; 1980 Nov; 177(5):551-5. PubMed ID: 6894774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease complicating myelopathy.
    Frisbie JH; Fisch B
    Paraplegia; 1992 Aug; 30(8):593-7. PubMed ID: 1523003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of ophthalmic Graves' disease.
    Agapitos PJ; Hart IR
    CMAJ; 1987 Feb; 136(4):369-72. PubMed ID: 3815199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the first stage of treatment with glucocorticoids and glucocorticoids with azathioprine].
    Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Daniel B
    Endokrynol Pol; 1988; 39(5):229-36. PubMed ID: 3076562
    [No Abstract]   [Full Text] [Related]  

  • 14. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eyelid malpositions in Graves' ophthalmopathy.
    Waller RR
    Trans Am Ophthalmol Soc; 1982; 80():855-930. PubMed ID: 6897828
    [No Abstract]   [Full Text] [Related]  

  • 17. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
    Smith TJ
    Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphocyte-subsets in endocrine exophthalmos.
    Cenmamo G; Bizzarro A; Castello G
    Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):43-5. PubMed ID: 3879963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the treatment by plasmapheresis (stage II) and cobalt teletherapy of orbital tissues (stage III)].
    Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Marzecki Z; Daniel B; Osiński W
    Endokrynol Pol; 1988; 39(5):237-44. PubMed ID: 3255604
    [No Abstract]   [Full Text] [Related]  

  • 20. Lid retraction and levator aponeurosis defects in Graves' eye disease.
    Frueh BR; Musch DC; Garber FW
    Ophthalmic Surg; 1986 Apr; 17(4):216-20. PubMed ID: 3754942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.